You are here

Fullerton Health rides Brexit risk aversion to sell 'AA' bonds

Tight pricing of S$100m issue attributed to a number of factors, including flight-to-quality flows


PRICING S$100 million of investment grade debt just days after Britain voted to leave the European Union (EU) may have helped Fullerton Healthcare Corp to benefit from flight-to-quality flows, Fullerton chief financial officer Ramesh Rajentheran said on Thursday.